Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
A synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) growth hormone secretagogue and ghrelin receptor agonist. GHRP-6 was the first synthetic GHRP developed (Bowers & Momany, 1984) and is defined by its pronounced appetite-stimulating effect — stronger than any other clinically studied GHRP. It is not FDA-approved and is used only as a research chemical.
0 of 6 vendors lab-verified
Verified purity per dollar — the cheapest that's actually been tested
vial · 5mg· moglabs.bio· price updated today
$16.00✓ $3.20/mg
single-vial price — packs may be lower
vial · 10mg· simplepeptide.com· price updated today
$39.00✓ $3.90/mg
18% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· realpeptides.co· price updated today
$50.00✓ $5.00/mg
36% more per mg vs cheapest
single-vial price — packs may be lower
vial · 5mg· ionpeptide.com· price updated today
$29.00✓ $5.80/mg
45% more per mg vs cheapest
single-vial price — packs may be lower
vial · 5mg· kimerachems.co· price updated 2w ago
$21.99✓ $4.40/mg
27% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· peptidetech.is· ⚠ price updated 1mo ago
$29.99$3.00/mg
single-vial price — packs may be lower
10 vendors not shown — trust grade below C, or not enough verified COA data yet. We only list sources with a C grade or better.
Best price trend
Lowest $/mg for GHRP-6 · verified listings only
$2.80/mg
flat
Verified Peptides has the lowest single-vial GHRP-6 price at $2.80/mg among 8 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower. That's 52% less per mg than the most expensive option.
What is the price range for GHRP-6?
Research-grade GHRP-6 ranges from $2.80/mg to $5.80/mg across 7 verified sources, a 52% spread per mg.
How are GHRP-6 prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
GHRP-6 was first characterized by Bowers, Momany, Reynolds, and Hong in Endocrinology (1984, PMID 6714155), establishing it as the first synthetic peptide to specifically release GH via a non-GHRH mechanism — a key tool in the later discovery of the ghrelin receptor. Ghigo et al. (European Journal of Endocrinology, 1997, PMID 9186261) reviewed the GHRP class and confirmed GH, ACTH/cortisol, and prolactin co-stimulation in humans. Berlanga et al. (Clinical Science, 2007, PMID 16989643) demonstrated ~78% infarct-mass reduction in a porcine myocardial infarction model via antioxidant mechanisms, and Berlanga-Acosta et al. (Clinical Medicine Insights: Cardiology, 2017, PMID 28469491) reviewed the cytoprotective GHRP literature across cardiac, neuronal, and hepatic tissues. GHRP-6 has never been approved for any clinical indication; its intense appetite stimulation and cortisol/prolactin co-release limit its clinical utility compared with ipamorelin.
This platform provides informational tools only, not medical advice.
On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone (Bowers et al.)
1984
Growth hormone-releasing peptides (Ghigo et al.)
1997
Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction (Berlanga et al.)
Prices verified as of July 2026. Actual prices may vary. For research use only.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
2007
Disclosed Labs